Vimta Labs Limited (NSE:VIMTALABS)
India · Delayed Price · Currency is INR 599.60
+1.15 (0.19%)
Sep 17, 2026, 3:30 PM IST
Vimta Labs Market Cap
Vimta Labs has a market cap or net worth of 26.68 billion as of September 16, 2026. Its market cap has decreased by -22.85% in one year.
Market Cap
26.68B
Enterprise Value
26.05B
Revenue
4.21B
Ranking
n/a
PE Ratio
33.49
Stock Price
599.60
ChartMarket Cap Chart
Since January 10, 2002, Vimta Labs's market cap has increased from 19.85M to 26.68B, an increase of 134,308.01%. That is a compound annual growth rate of 33.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 26.68B | -1.41% |
| Dec 31, 2025 | 27.06B | 22.39% |
| Dec 31, 2024 | 22.11B | 147.00% |
| Dec 29, 2023 | 8.95B | -7.56% |
| Dec 30, 2022 | 9.68B | 7.16% |
| Dec 31, 2021 | 9.04B | 134.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.45T |
| Divi's Laboratories | 2.43T |
| Apollo Hospitals Enterprise | 1.25T |
| Lenskart Solutions | 1.18T |
| Ind-Swift Laboratories | 31.65B |
| Dishman Carbogen Amcis | 25.41B |
| Sakar Healthcare | 24.60B |
| Indoco Remedies | 23.45B |